Our Services
Medical Information
Helpful Resources
Published on: 7/21/2026
Mounjaro (tirzepatide) can modestly lower blood pressure and increase the risk of orthostatic hypotension—a sudden drop in blood pressure when standing up that may cause lightheadedness, dizziness, blurred vision, weakness, brief blackouts, or fainting. Recognizing these symptoms early is essential for staying safe during treatment.
Your individual risk depends on several factors, including hydration status, other medications, and underlying conditions. Simple preventive steps can help: stay well-hydrated, rise slowly from sitting or lying positions, consider compression stockings, and monitor your blood pressure regularly.
If you're experiencing dizziness, fainting, or other concerning symptoms on Mounjaro, don't guess what's causing them. Every person's response to tirzepatide is different, and symptoms that seem minor can sometimes signal issues that need prompt attention. Take a free, instant, online symptom check to better understand what may be behind your symptoms and get clear guidance on your next steps—whether that's a simple lifestyle adjustment or a conversation with your doctor.
Reviewed for medical accuracy: 07/21/2026
If you're taking Mounjaro (tirzepatide) for type 2 diabetes or weight management, you may notice occasional lightheadedness when you stand up quickly. This is often due to a drop in blood pressure—known as orthostatic hypotension—and can lead to fainting spells if not addressed. Understanding Mounjaro and low blood pressure dangers and taking simple precautions can help you stay safe and enjoy the benefits of your medication without unnecessary risk.
When you rise from sitting or lying down quickly:
On Mounjaro, the usual reflexes that tighten blood vessels and raise heart rate can be blunted by its blood-pressure lowering effects. The result? A greater chance of orthostatic hypotension and, in some cases, a brief loss of consciousness (syncope).
Be alert for symptoms of orthostatic hypotension:
If you experience any of these, especially more than once, it's time to take action.
Hydration is Key
Rise Slowly
Increase Salt Intake (if appropriate)
Eat Small, Frequent Meals
Wear Compression Stockings
Monitor Your Blood Pressure
Avoid Triggers
Strengthen Your Core and Legs
Occasional mild dizziness may be manageable with lifestyle changes. However, discuss with your doctor if you experience:
If any symptom feels life-threatening or you lose consciousness, call emergency services immediately.
Sometimes, a vasovagal reflex (a sudden drop in heart rate and blood pressure) mimics orthostatic hypotension. If you're experiencing sudden fainting or lightheadedness and want to understand whether it could be related to Vasovagal Reflex, Ubie's free AI-powered symptom checker can help you identify your symptoms and determine the best next steps for care.
Your safety is as important as the benefits you gain from Mounjaro. By adopting simple preventive measures and staying aware of Mounjaro and low blood pressure dangers, you can reduce your risk of fainting spells and focus on your treatment goals.
Always speak to a doctor about any new, persistent, or severe symptoms or before making changes to your treatment plan. Your provider will help tailor advice to your unique health needs.
(References)
* Li Z, Liu C, Lu X, Wang C, Jiang S, Jin M, Lv X, Zhao F, Lu Y. Safety and Tolerability of Tirzepatide in Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diabetes Metab Syndr Obes. 2023 Feb 1;16:355-367. doi: 10.2147/DMSO.S400612. PMID: 36741708; PMCID: PMC9897040.
* Dhillon S. Tirzepatide: A Review in Type 2 Diabetes. Drugs. 2022 Aug;82(12):1309-1322. doi: 10.1007/s40265-022-01755-6. PMID: 35915124.
* Zhang X, Yu S, Zheng Y, Yu S. Adverse Events of Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Meta-Analysis. Diabetes Obes Metab. 2020 Jun;22(6):898-908. doi: 10.1111/dom.13961. Epub 2020 Feb 21. PMID: 32087093.
* Frías JP, Nauck MA, Van J, Cudkowicz C, Jaros M, Cilissen C, Stock EG, Karmaker D, Haupt A, Milicevic Z, Rob either M. Tirzepatide: A Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes. Diabetes Ther. 2022 Mar;13(3):397-420. doi: 10.1007/s13300-022-01211-5. Epub 2022 Jan 27. PMID: 35084799; PMCID: PMC8889104.
* Shieh S, Vella-Brincat J, Brincat J, Barden AE, Watts GF, Ng J, O'Gorman D. A Review of Hypoglycemia-Related Adverse Events in Patients with Type 2 Diabetes Mellitus Treated with Glucagon-Like Peptide-1 Receptor Agonists. Adv Ther. 2022 Jan;39(1):15-28. doi: 10.1007/s12325-021-01962-9. Epub 2021 Dec 6. PMID: 34873722; PMCID: PMC8752003.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.